The long-term goal of this project is to expand the range of therapies for bacterial infections that: 1) can effectively treat even antibiotic-resistan organisms; and 2) do not contribute to the further development of antibiotic resistance. This project will explore a new approach using photodynamic therapy for urinary tract infections in people who use catheters for medical purposes. Over a million cases of urinary tract infections are diagnosed each year in this population, and the repeated use of antibiotics to treat these infections is contributing to the spread of drug-resistant organisms. This new approach combines two common and inexpensive drugs (methylene blue, MB and potassium iodide, KI) that will be delivered to the bladder of infected patients and then will be activated by a fiber-opic light source introduced into the bladder. This newly discovered drug combination is synergistic and KI enhances killing by up to 1000-fold compared to the killing using light and MB alone. The light treatment should be applied almost immediately after drug treatment to spare the normal bladder tissue. This approach may enable the eradication of urinary tract infections without the use of antibiotics and without the potential to encourage development of additional treatment resistant in target organisms. Only initial bench studies have been done on the use of photodynamic therapy to treat urinary tract infections. Therefore, the specific aims of this projec are to show that the specific drug combination activated by light can effectively kill a range of bacteria that cause urinary tract infections, including those that are antibiotic-resistant; and tht this photodynamic therapy can be used to eradicate bacterial infections without causing significant damage to the bladder. In the first phase of this project studies will be done with an already-identified drug combination, testing it in bacterial cultures and in small animal models. I the second phase of the project, studies will be done to identify new second generation drug combinations and less expensive LED light sources in order to make treatment more effective and less expensive. Finally, an optimized treatment combination will be tested in a pig model, where the bladder is similar to a human bladder, to show that the photodynamic therapy can eradicate the same kind of bacteria that infect people who have urinary tract infections caused by catheter use.

Public Health Relevance

Over a million cases of urinary tract infections are diagnosed each year in people who use urinary catheters for medical purposes, and the repeated use of antibiotics to treat these infections contributes to the spread of antibiotic-resistant bacteria. Tis project addresses U.S. public health by investigating a different method of killing bacteria and treating bladder infections that does not use antibiotics and does not contribute to the further development of antibiotic resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI121700-02
Application #
9180682
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Ernst, Nancy Lewis
Project Start
2015-12-01
Project End
2017-11-30
Budget Start
2016-12-01
Budget End
2017-11-30
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Wen, Xiang; Li, Yong; Hamblin, Michael R et al. (2017) Facial Manifestations of Pachydermoperiostosis Treated with Botulinum Toxin Type-A: Report of 3 Cases. Acta Derm Venereol 97:761-762
Vatansever, Fatma; Hamblin, Michael R (2017) Surface-Initiated Polymerization with Poly(n-hexylisocyanate) to Covalently Functionalize Silica Nanoparticles. Macromol Res 25:97-107
El-Hussein, Ahmed; Hamblin, Michael R (2017) ROS generation and DNA damage with photo-inactivation mediated by silver nanoparticles in lung cancer cell line. IET Nanobiotechnol 11:173-178
Costley, David; Nesbitt, Heather; Ternan, Nigel et al. (2017) Sonodynamic inactivation of Gram-positive and Gram-negative bacteria using a Rose Bengal-antimicrobial peptide conjugate. Int J Antimicrob Agents 49:31-36
Djavid, Gholamreza Esmaeeli; Bigdeli, Bahareh; Goliaei, Bahram et al. (2017) Photobiomodulation leads to enhanced radiosensitivity through induction of apoptosis and autophagy in human cervical cancer cells. J Biophotonics 10:1732-1742
Hamblin, Michael R (2017) Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol :
Wen, Xiang; Li, Yong; Hamblin, Michael R (2017) Photodynamic therapy in dermatology beyond non-melanoma cancer: An update. Photodiagnosis Photodyn Ther 19:140-152
Wang, Yucheng; Wang, Ying; Wang, Yuguang et al. (2017) Antimicrobial blue light inactivation of pathogenic microbes: State of the art. Drug Resist Updat 33-35:1-22
Freitas, L F; Hamblin, M R; Anzengruber, F et al. (2017) Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro. J Photochem Photobiol B 173:181-186
Wainwright, Mark; Maisch, Tim; Nonell, Santi et al. (2017) Photoantimicrobials-are we afraid of the light? Lancet Infect Dis 17:e49-e55

Showing the most recent 10 out of 45 publications